Nanobiotix | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,001.60
32,986.50
17,003.20
21,058.00
47,212.50
36,203
Total Accounts Receivable
1,692.60
2,044.20
4,737.10
5,027.50
4,897.30
5,352
Other Current Assets
199.50
473.90
1,207.70
804.80
998.90
1,096
Total Current Assets
6,893.70
35,504.70
22,947.90
26,890.30
53,108.70
42,651
Net Property, Plant & Equipment
467.70
1,291.80
2,431.50
2,431.80
2,990.30
2,884
Total Investments and Advances
68.10
-
813.10
500.10
500.10
-
Intangible Assets
9.10
9.90
7.50
4.50
136.00
102
Other Assets
-
247.40
-
333.80
458.70
382
Total Assets
7,438.70
37,053.80
26,200.10
30,160.50
57,193.80
46,019
ST Debt & Current Portion LT Debt
231.00
321.00
1,070.30
1,084.20
769.50
Accounts Payable
1,348.80
2,234.60
3,585.20
4,373.90
5,143.50
Income Tax Payable
66.30
85.60
312.90
168.80
229.60
Other Current Liabilities
1,635.90
1,782.90
2,133.80
2,619.10
3,208.80
Total Current Liabilities
3,282.00
4,424.10
7,102.20
8,246.10
9,351.50
Long-Term Debt
875.20
2,002.00
3,530.80
4,583.10
3,959.80
Provision for Risks & Charges
99.80
312.30
173.90
175.20
233.50
Total Liabilities
4,256.90
6,738.40
10,807.00
13,004.40
13,544.70
Common Equity (Total)
3,181.80
30,315.30
15,393.10
17,156.10
43,649.00
Total Shareholders' Equity
3,181.80
30,315.30
15,393.10
17,156.10
43,649.00
Total Equity
3,181.80
30,315.30
15,393.10
17,156.10
43,649.00
Liabilities & Shareholders' Equity
7,438.70
37,053.80
26,200.10
30,160.50
57,193.80

About Nanobiotix

View Profile
Address
60, rue de Wattignies
Paris Ile-de-France 75012
France
Employees -
Website http://www.nanobiotix.com
Updated 07/08/2019
Nanobiotix SA engages in the development of nanoparticle-based technologies for the treatment of cancer. The company's technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. It also engages in the development of magnetic particles and laser activated nanoparticles for the treatment and diagnosis of cancer.